Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Queensland Health
Baxter
Deloitte
Cerilliant
Merck
Farmers Insurance
Fuji
Julphar
Federal Trade Commission

Generated: December 11, 2017

DrugPatentWatch Database Preview

Patent Applications for SUTENT

« Back to Dashboard

US Patent Applications for SUTENT

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
► Subscribe► SubscribeMETHODS OF MODULATING C-KIT TYROSINE PROTEIN KINASE FUNCTION WITH INDOLINONE COMPOUNDS2000-12-22Abandoned -- Failure to Pay Issue Fee2003-07-23
► Subscribe► SubscribePYRROLE SUBSTITUTED 2-INDOLINONE PROTEIN KINASE INHIBITORS2001-02-15Patented Case2003-05-14
► Subscribe► SubscribeTreatment of acute myeloid leukemia with indolinone compounds2002-10-28Abandoned -- Failure to Respond to an Office Action2006-02-04
► Subscribe► SubscribeINDOLINONE PROTEIN KINASE INHIBITORS AND CYCLOOXYGENASE INHIBITORS FOR USE IN COMBINATION THERAPY FOR THE TREATMENT OF CANCER2002-08-15Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622012-02-20
► Subscribe► SubscribePROCESS FOR PREPARING INDOLINONE DERIVATIVES2003-02-14Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622010-11-08
► Subscribe► SubscribeONCOKINASE FUSION POLYPEPTIDES ASSOCIATED WITH HYPERPROLIFERATIVE AND RELATED DISORDERS, NUCLEIC ACIDS ENCODING THE SAME AND METHODS FOR DETECTING AND IDENTIFYING THE SAME2003-08-08Patented Case2007-03-07
► Subscribe► SubscribePyrrole substituted 2-indolinone protein kinase inhibitors2003-04-14Abandoned -- Failure to Respond to an Office Action2005-04-15
► Subscribe► SubscribeMANNICH BASE PRODRUGS OF 3-(PYRROL-2-YL-METHYLIDENE)-2-INDOLINONE DERIVATIVES2003-12-24Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622010-06-28
► Subscribe► SubscribePRODRUGS OF A 3-(PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES2004-04-05Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622010-06-28
► Subscribe► SubscribeTreatment of excessive osteolysis with indolinone compounds2004-02-19Abandoned -- Failure to Respond to an Office Action2009-07-06
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

WIPO Patent Applications for SUTENT

WIPO Patent Application Title Patent Filing Date
► Subscribe
► Subscribe
► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Federal Trade Commission
Dow
Moodys
Novartis
Queensland Health
Healthtrust
UBS
Citi
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot